These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2561185)

  • 1. Mode of action of itraconazole: morphological aspects.
    Borgers M; Van de Ven MA
    Mycoses; 1989; 32 Suppl 1():53-9. PubMed ID: 2561185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degenerative changes in fungi after itraconazole treatment.
    Borgers M; Van de Ven MA
    Rev Infect Dis; 1987; 9 Suppl 1():S33-42. PubMed ID: 3027844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro antifungal spectrum of itraconazole.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():7-13. PubMed ID: 2561189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D; Barchiesi F; Ancarani F; Scalise G
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale.
    Faergemann J; Borgers M
    Acta Derm Venereol; 1990; 70(2):172-6. PubMed ID: 1969209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole, a new triazole that is orally active in aspergillosis.
    Van Cutsem J; Van Gerven F; Van de Ven MA; Borgers M; Janssen PA
    Antimicrob Agents Chemother; 1984 Oct; 26(4):527-34. PubMed ID: 6097167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of saperconazole on the morphology of Candida albicans, Pityrosporum ovale and Trichophyton rubrum in vitro.
    Jansen T; Borgers M; van de Ven MA; Xhonneux B; Wouters L; van Gerven F; van Cutsem J
    J Med Vet Mycol; 1991; 29(5):293-303. PubMed ID: 1955949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Morera-López Y; Torres-Rodríguez JM; Jiménez-Cabello T
    Rev Iberoam Micol; 2005 Jun; 22(2):105-9. PubMed ID: 16107169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole activity against fungal germination.
    Strippoli V; Simonetti N; Retico A; Lucchetti G
    Drugs Exp Clin Res; 1988; 14(5):341-5. PubMed ID: 2851427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of azole-antifungal agents on the regulation of intracellular calcium concentration of Trichophyton rubrum.
    Inoue I; Seishima M; Osada K; Kitajima Y
    J Dermatol Sci; 1996 Jun; 12(2):156-62. PubMed ID: 8814548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale.
    Marichal P; Gorrens J; Van Cutsem J; Van Gerven F; Vanden Bossche H
    J Med Vet Mycol; 1986 Dec; 24(6):487-9. PubMed ID: 3033190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies with R 51,211 (itraconazole).
    Espinel-Ingroff A; Shadomy S; Gebhart RJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K; Hosaka J; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.